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A Correlation between TCR V Docking
on MHC and CD8 Dependence:
Implications for T Cell Selection
phic CDR regions make all the contacts with the MHC
and peptide, with the CDR3 loops positioned over the
center of the peptide in the peptide binding groove of
the MHC (Garboczi and Biddison, 1999; Garboczi et
al., 1996). Thus, the most variable region of the TCR is
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The cocrystal structures of TCR and pMHC deter-University of North Carolina
mined to date have shown a similar docking orientationChapel Hill, North Carolina 27599
of TCR on pMHC. The TCR V domain is positioned4 Laboratory of Cell Biology
over 2 of the MHC near the amino terminus of theNational Cancer Institute
peptide, while the V domain is found atop the MHCNational Institutes of Health
1 domain near the carboxyl terminus of the peptideBethesda, Maryland 20892
(Garboczi and Biddison, 1999; Rudolph and Wilson,5 Molecular Immunology Section
2002). The KB5-C20 TCR was recently shown to undergoNeuroimmunology Branch
large conformational change upon binding of pKB1/KbNational Institute of Neurological Disorders and Stroke
in order to preserve this binding mode (Reiser et al.,National Institutes of Health
2002). The TCR/MHC binding angle is often referredBethesda, Maryland 20892
to as “diagonal,” yet the existing crystallographic data
demonstrates that the angle the TCR makes with the
peptide binding groove of the MHC may vary from45
Summary to 80 (Rudolph and Wilson, 2002). The most recent spec-
tacular departure from a diagonal orientation comes
T cell receptors (TCR) adopt a similar orientation when from an immunodominant flu-specific, A2-restricted
binding with major histocompatibility complex (MHC) TCR JM22 (Stewart-Jones et al., 2003). When the first
molecules, yet the biological mechanism that gener- class II MHC/TCR structure was determined, it was
ates this similar TCR orientation remains obscure. We speculated that Class II-restricted TCR bound in an
show here the cocrystallographic structure of a mouse orthogonal manner while Class I-restricted TCR con-
TCR bound to a human MHC molecule not seen by formed to a diagonal orientation (Reinherz et al., 1999).
the TCR during thymic development. The orientation However, this idea of orthogonally oriented Class II-
of this xenoreactive murine TCR atop human MHC restricted TCR and diagonally oriented Class I TCR
deviates from the typical orientation more than any was proposed when few Class I MHC/TCR structures
previously determined TCR/MHC structure. This unique were available. Currently, the existing TCR/pMHC struc-
orientation is solely due to the placement of the TCR tural database puts the orientation angle for Class II-
V domain on the MHC. In light of new information restricted TCR into the range of angles seen for Class
provided by this structure, we have reanalyzed the I-restricted TCR.
existing TCR/MHC cocrystal structures and discov- It would be reasonable to expect that the common
ered unique features of TCR V domain position on mode of binding would be governed by a set of con-
class I MHC that correlate with CD8 dependence. Fi- served interactions between the TCR and pMHC. Sur-
nally, we propose that the orientation seen in TCR prisingly, no conserved interactions have been identified
recognition of MHC is a consequence of selection dur- in the different cocrystal structures of MHC and TCR
ing T cell development. that explain the common docking. Additionally, alanine
scanning mutagenesis of both TCR and pMHC contact
surfaces have failed to identify residues that are crucialIntroduction
for determining that orientation (Baker et al., 2001; Man-
ning et al., 1998; Wang et al., 2002).ClonotypicT cell receptors (TCR) on the T cell surface
During T cell development in the thymus, T cells arespecifically interact with peptides bound to major histo-
selected based on their ability to recognize self-MHCcompatibility complex (pMHC) molecules. Recognition
molecules. Although the molecular mechanisms under-
of the pMHC by the TCR is required for activation and
lying T cell selection are not entirely clear, mounting
subsequent killing by cytolytic T cells. Proper immune
experimental evidence supports a quantitative/avidity
system function requires a large repertoire of T cells that model of thymocyte selection, which predicts that avid-
are responsible for recognition of any foreign peptide ity of the TCR/MHC interaction determines whether or
bound to self-MHC. This large repertoire of T cells is not an immature T cell will survive the selection process
created by splicing of TCR variable domains containing (Sebzda et al., 1999). Thus, during positive selection,
complementarity determining regions CDR1 and CDR2, those thymocytes that survive will have at least low
and by joining of TCR variable and constant domains avidity for self-pMHC. Conversely, presumably in order
to form the CDR3 region in both the  and  chains to avoid rampant autoimmune disease, high avidity
(reviewed in Davis and Bjorkman, 1988). The polymor- T cells are eliminated by apoptosis during negative se-
lection.
In addition to the processes of positive and negative*Correspondence: edward_collins@med.unc.edu
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selection, immature thymocytes make a CD4 or CD8 p1027/Db show that AHIII 12.2 TCR cannot recognize
similar molecular surfaces (Zhao et al., 1999).lineage commitment while in the thymus. Instructional
In order to examine xenoreactive TCR/pMHC interac-and stochastic models of lineage commitment have
tions directly, the ectodomains from the  and  chainsbeen proposed. The instructional model says that com-
of the AHIII 12.2 TCR were cloned from the AHIII 12.2mitment is controlled with a unique signal specifying
T cell and expressed in E. coli (Buslepp et al., 2003).differentiation into CD4 or CD8 T cells. The stochastic
The cocrystallographic structure of the murine AHIII 12.2model says the decision to become CD4 or CD8
TCR bound to human HLA-A2 with the peptide p1049T cells is random, and T cells that make the wrong
(ALWGFFPVL) was determined. This xenoreactive mu-decision are eliminated. Recent data support the in-
rine TCR docks almost exactly perpendicular to the pep-structional model. The popular “strength of signal” the-
tide binding groove of the human pMHC, and thus isory proposes that short duration p561ck signals result in
the furthest departure from a “diagonal” orientation seenCD8 commitment, while higher intensity/longer duration
so far for a TCR/pMHC cocrystal complex. This deviationsignals result in CD4 commitment (Germain, 2002). Re-
from the current structural ideology of TCR and pMHCgardless of the exact mechanism, the outcome of T cell
when examined with other biological data suggests adevelopment is a finely tuned repertoire of CD4 and
requirement for a specific molecular geometry duringCD8 T cells, responsible for the identification of all
T cell selection.foreign antigens, but only in the context of self-MHC.
Although detection of foreign peptides bound to self-
ResultsMHC is the function of T cells, it is estimated that
1%–10% of TCR react to non-self MHC molecules (allo-
Crystallographic data (30–2.0 A˚) were collected from areactivity or xenoreactivity). The ability of a single TCR to
single crystal of the ectodomains of the murine TCRrecognize two distinct peptide/MHC complexes, termed
AHIII 12.2 and the human class I MHC complex p1049/T cell crossreactivity, occurs frequently and has been
A2 (ALWGFFPVL). The unambiguous molecular replace-suggested to be critical to recognition of foreign antigen
ment solution showed two identical complexes of TCR/(Mason, 1998). It had been proposed that T cell cross-
pMHC in the asymmetric unit. The crystallographicreactivity was the result of similarities in the charge
structure is well refined to an Rfree of 25.3% fromand/or shape of the antigenic surface presented to the
30.0–2.0 A˚. Data and refinement statistics may be foundTCR, an idea termed molecular mimicry. Recent struc-
in Table 1. The structure of p1049/A2 has no significanttural studies of crossreactive TCR ligands demonstrate
differences when compared to the uncomplexed proteinthat crossreactivity is not necessarily due to any obvious
(Zhao et al., 1999). The structure of the AHIII TCR isresemblance between pMHC surfaces (Reiser et al.,
similar to the structures of other TCR determined to date2003; Zhao et al., 1999). Instead, studies with altered
(Ding et al., 1998; Garboczi et al., 1996; Garcia et al.,peptide ligands (APL) and the cocrystal structures of
1998; Hennecke et al., 2000; Kjer-Nielsen et al., 2003;TCR bound to pMHC ligands have highlighted the plas-
Reinherz et al., 1999; Reiser et al., 2000, 2002; Stewart-
ticity of TCR antigen recognition (Ding et al., 1999; Gar-
Jones et al., 2003). The TCR of the xenoreactive complex
cia et al., 1998). In fact, when TCRs with high affinity
is bound to the MHC peptide binding cleft in a manner
and high peptide specificity (hence presumably less
analogous to recognition of other TCR examined crystal-
plasticity) were made in vitro, crossreactivity increased lographically (Figure 1). The variable domains are posi-
dramatically (Holler et al., 2003). tioned above the peptide binding groove with the CDR3
It is not known whether TCR that recognize a MHC loops from each chain positioned above the center of
from a different species would interact in a different the peptide. The positions of the constant domains rela-
manner than found for TCR recognition of self-MHC. tive to the variable domains of the AHIII 12.2 TCR are
Xenoreactivity is of particular interest, as no evolutionary slightly different from other individual TCR (not shown),
advantage would be conferred to a species’ T cells that but these changes are within the range found in the
retain the ability to recognize MHC from another species, structures of TCRs in general (Rudolph and Wilson,
since divergence occurred several million years ago. 2002).
Nevertheless, xenografts are eventually rejected due, There are two nearly identical copies of the TCR/
in part, to the T cell cytotoxicity resulting from MHC pMHC complexes in the asymmetric unit of the crystal.
mismatch. In order to examine this phenomenon in de- These TCR/pMHC complexes are in the same orienta-
tail, we are studying a murine-derived AHIII 12.2 T cell tion such that a simple lateral translation relates the two
as a model for xenogeneic transplant rejection. AHIII copies. These two complexes suggest a manner for
12.2 T cells were selected in the H2b mouse (C57Bl/6), TCR oligomerization on T cells that has been previously
but are xenoreactive (Engelhard and Benjamin, 1982) proposed to be important for T cell signaling (Bachmann
and recognize the human MHC HLA-A*0201 (A2) and a et al., 1998; Rotzschke et al., 1997). However, when the
human self-peptide called p1049 (Henderson et al., structure of A2 bound to CD8 is superimposed on one
1993). The AHIII 12.2 T cell also recognizes mouse class copy of p1049/A2 bound to AHIII 12.2 (Gao et al., 1997;
I MHC, H2-Db (Db) and the peptide (p1058) (Loftus et al., Kern et al., 1998), the CD8 molecule and the TCR from
1997). The AHIII 12.2 T cell is CD8 independent with the second p1049/A2/AHIII 12.2 complex occupy the
respect to recognition of the human pMHC (p1049/A2), same location in space. Therefore, we conclude that this
yet proliferation and cytolysis are not different from en- pair of complexes cannot represent a physiologically
gagement of a pMHC (p1058/Db) that requires CD8 (Bus- meaningful oligomer, and that this dimer is a crystalliza-
tion artifact.lepp et al., 2003). The crystal structures of p1049/A2 and
A Xenoreactive TCR Docks Nondiagonally
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with respect to the path of the peptide spans from 44Table 1. Data and Refinement Statistics for AHIII 12.2:p1049/A2
to 84 for TCR other than AHIII 12.2; AHIII 12.2 docks
Data Collection
at 89. It is clear from the comparison that the orientation
Space Group P21 of the variable domains are not fixed at a specific posi-
Cell Dimensions a  93.71 A˚, b  84.47 A˚, tion on the MHC particularly with respect to the lateral
c  121.34 A˚,   92.13
position of the domain along the peptide. 2C, KB5-C20,Molecules/AU 2
A6, and B7 are found in a common orientation. The entireResolution 30.0–2.0 A˚
BM3.3 and LC13 TCRs are found shifted toward theRmerge(%)a 7.4 (57.8)
I/ 28.5 (3.5) carboxyl terminal end of the peptide. The orientation of
Unique reflections 121,366 the AHIII 12.2 TCR may be described as orthogonal to
Average redundancy 7.5 the direction of the peptide. This is similar to the recently
Completeness (%) 99.9 (99.9)
described structure of the immunodominant TCR JM22Solvent content 46%
(Stewart-Jones et al., 2003), but more pronounced inRefinement
terms of the orthogonality. Additionally, the Class II-Resolution Range 30.0–2.0 A˚
Number Reflections (Rfac/Rfree) 114,945/6,421 restricted TCR D10 and HA1.7 have been termed orthog-
Rfac 21.9 (24.4) onal (Hennecke et al., 2000; Reinherz et al., 1999), but
Rfree 25.3 (29.4) at 80 and 70, respectively, these two TCRs bind MHC
Number of non-hydrogen atoms 13,255
in a more diagonal orientation than AHIII 12.2 and JM22Number water molecules 432
(Figure 2I; Table 2). The large distribution of TCR posi-Mean B value 14.2 A˚2
tions suggests that the angle (orientation) of binding ofCoordinate error 0.179 A˚
Rs fit 89.0% TCR to pMHC is not critical to T cell function.
Deviations from ideality The center of mass of the V domain of AHIII 12.2 is
—Bond lengths 0.012 A˚ found almost midway between the amino and carboxyl
—Bond angles 1.435o
termini of the peptide (Figure 2H). Interestingly, the posi-Ramachandran
tions of the V domains’ of the Class I-restricted TCRMost favorable 89.7%
seem to cluster into two distinct sets. Four V domainsAdditionally allowed 9.9%
Generously allowed 0.4% cluster together at a position closer to the amino termi-
Disallowed 0.0% nus of the peptide. Group a includes 2C, A6, B7, and
KB5-C20. Group b includes BM3.3, LC13, JM22, anda Rmerge	hkl	i |Ii
I|/	hkl	i Ii, where Ii is the observed intensity and
I is the average intensity of multiple observations of symmetry AHIII 12.2 with V domains significantly different from
related reflections. those of the group a position. As compared to the aver-
b Number in parenthesis refers to the highest resolution shell age position of all eight domains, the two groups are
(2.05–2.00 A˚) significantly different using a grouped-pair Student’s Tc R  	hkl||Fobs| 
 k|Fcal||/	hkl|Fobs|, where Rfree is calculated for a ran- test (p  0.01). When compared to the average positiondomly chosen 5% of reflections, Rwork is calculated for the remaining
of group b (represented by BM3.3, LC13, AHIII12.2, and95% of reflections used for structure refinement. Numbers in paren-
thesis refer to the number of structure factors used in the measure- JM22 in Figure 2h), the positions of each of the other
ments. four are significantly different (p .003). The Vdomains
dRs fit is the average real space fit of all atoms on a 2fo-fc also appear to group into two locations, one near the
electron density map. center and the other toward the carboxyl terminus ofe Error is the mean coordinate error estimate based on maximum
the peptide. Attempts to rationalize these groupingslikelihood measurements (Murshudov, 1997; Pannu and Reed, 1996)
suggested some functional importance to the position
of the V or V domain and that BM3.3, LC13, JM22,
and AHIII 12.2 share a common but as yet unknownOrientation of TCR Docking on pMHC
feature. What was found is BM3.3 (Guimezanes et al.,Structural studies of four human Class I pMHC com-
2001), LC13 (S. Burrows and B. Jakobsen, personalplexes with unique human TCR (TCR  A6, B7, and
communication), JM22 (Lawson et al., 2001), and AHIIILC13 and JM22) and three mouse Class I pMHC com-
12.2 (Buslepp et al., 2003) are all CD8 independent.plexes with unique murine TCR (TCR  2C, BM3.3, and
These data are summarized in Table 2.KB5-C20) have established that TCR dock diagonally
with respect to the orientation of the peptide in the
peptide binding groove with large variances in the diago- Interactions between AHIII 12.2 and p1049/A2
AHIII 12.2 xenoreactively recognizes p1049/A2. We sus-nal nature (reviewed in Rudolph and Wilson, 2002). Fig-
ures 2A–2G show the molecular surface of the variable pected that the interactions between murine AHIII 12.2
TCR and human p1049/A2 may be different than ob-domains of the TCR atop the pMHC surface shown in
shades of gray. The molecular surfaces of these pre- served from other TCR/pMHC complexes because the
mouse AHIII 12.2 did not encounter HLA-A2 during T cellviously published TCR are shown in various colors, to
compare the orientation with respect to the molecular selection. Some differences are observed during xeno-
reactive T cell recognition, as opposed to syn or allo-surface of the AHIII 12.2 TCR shown in green in each
panel. These data show that orientation of AHIII 12.2 is recognition. There are significantly more interactions (H
bonds, water bridges, van der Waals interactions be-significantly different from the other TCRs (except JM22)
and is not in a diagonal orientation when bound to tween 2 and 4 A˚) between AHIII 12.2 and p1049/A2 (163)
than seen for other TCR/pMHC complexes (p  0.003).p1049/A2. Figure 2H shows the orientations of the TCR
schematically with a ball representing the center of mass The next closest TCR with a large number of interactions
is LC13 with 150 followed by A6 with 127 interactions.of each variable domain. The angle that these TCR take
Immunity
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Figure 1. The Structure of AHIII 12.2 Bound to Xenogeneic p1049/A2
The stereo view of AHIII 12.2 TCR is depicted as a ribbon (Carson, 1987) in magenta ( chain) and blue ( chain). The A2 heavy chain is silver,
2m is cyan, and the p1049 peptide is gold.
The largest differences in interactions are found be- through selection on A2, it was not negatively selected
and survived. Alloreactive TCR appear to preferentiallytween the AHIII 12.2 V domains and V domains of
other pMHCs (Figure 3A). In AHIII 12.2 and p1049/A2, use their  chains to make the majority of interactions
(Rudolph and Wilson, 2002), but the number and typethe pMHC/V interactions are dominated by van der
Waals contacts to the MHC. The other TCR have more of interactions found between the V domain of AHIII
12.2 and p1049/A2 are not increased as compared toequally distributed types of interactions, and inter-
actions with the peptide predominate. It appears rea- other TCR V domains (Figure 3B).
The total surface of A2 buried by AHIII 12.2 TCRsonable to suggest that large numbers of specific in-
teractions between TCR and MHC would result in high (981 A˚2) is very similar to the average buried surface
area (957 A˚2 sd 164 A˚2) of other complexes (Figure 3C).self-affinity and negative selection. AHIII 12.2, which
was not selected on A2 during development in the thy- The buried surface area of the p1049 peptide (250 A˚2) is
not significantly different from the mean of other pep-mus, may use more van der Waals contacts to recognize
p1049/A2, specifically because since it did not go tides (226.7 A˚2, sd 72 A˚2). Although the shape comple-
A Xenoreactive TCR Docks Nondiagonally
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Figure 2. The Orientations of TCR Docked on Class I MHC Are Not Conserved to Diagonal
The orientation of AHIII 12.2 docking is most orthogonal when compared to other TCR/pMHC structures and V positions fall into two distinct
groups. Class I MHC from TCR/pMHC cocrystal structures were superimposed onto p1049/A2 bound to AHIII 12.2. Molecular surfaces of the
V and V domains from those TCR are shown in addition to the variable domains of AHIII 12.2 (green) in order to compare the orientations
of the TCR on the MHC. (A) 2C (red), (B) KB5-C20 (light blue), (C) A6 (dark blue), (D) B7 (gold), (E) BM3.3 (cyan), and (F) LC13 (magenta). (G)
JM22 (yellow). (H) The positions of the center of mass of each TCR V and V domain are given pseudo-atoms and the positions connected
by a line to demonstrate the orientation that each TCR docks onto the MHC. The different TCR are colored as in (A)–(G). The p1049/A2
complex is shown as a molecular surface representation with the peptide colored yellow. (I) The orientation of V/V pairs of TCR docking
on class II MHC compared to AHIII 12.2. HA1.7 is shown in dark blue and D10 in light blue. AHIII 12.2 is shown in green. (A)–(I) were constructed
with Grasp (Nicholls et al., 1991).
mentarity of the interface between AHIII 12.2 and p1049/ interactions (Lawrence and Coleman, 1993), it is not
significantly different from the complementarity seen inA2 is the highest of the cocrystal structures examined to
date at 71.6%, and approaches that of antibody:antigen the other TCR/pMHC cocrystal structures (Figure 3D).
Immunity
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Table 2. Correlation of TCR V Position and CD8 Dependence
Group by V
TCR/pMHC position (Figure 2h) CD8-dependent? Docking Angle
AHIII 12.2/p1049/A2 a No (Buslepp et al., 2003) 89
BM3.3/pBM1/Kb a No (Guimezanes et al., 2001) 58
LC13/FLRGRAYGL/B8 a No (Sewell et al, 1999) 57
JM22/MP/A2 a No (Lawson et al., 2001) 84
2C/SIYR/Kb b Yes (Daniels et al., 2000) 44
A6/Tax/A2 b Yes (data not shown) 58
B7/Tax/A2 b Yes (data not shown) 72
KB5-C20/pKB1/Kb b Yes (Guimezanes et al. 2001) 45
Docking angles are measured as the angle from the line formed by the amino and carboxyl ends of the class I MHC bound peptide.
The worst surface complementarity described is be- between other TCR/pMHC whose cocrystal structures
have been determined (Rudolph and Wilson, 2002)tween the 2C TCR and SIYR/Kb (Garcia et al., 1998).
However, surface complementarity also does not strictly
correlate with affinity between the complexes. The affin- Recognition of Peptide
As observed in other TCRs cocrystallized with pMHC,ity of AHIII 12.2 is relatively high (10 M) (Buslepp et
al., 2003), but it is not higher than the affinities observed the interactions of AHIII 12.2 with peptide are primarily
Figure 3. Comparison of the Interactions between AHIII 12.2 and p1049/A2 Other TCR/pMHC Complexes
(A) The contacts between TCR V domains and pMHC within 4.0 A˚ are divided into van der Waals (vdW) for MHC (or peptide) or hydrogen
bonds (H-bonds) for MHC (or peptide) and for waters that make hydrogen bonds with both TCR and MHC or peptide (bridging) with color-
coding as shown in the legend. Note that not all structures were of sufficient resolution to include waters in the model. Residues with 2.0 and
4.0 A˚ were determined using the program Contact (Dodson, 1997).
(B) The contacts between TCR V domains with pMHC as shown as described in (A).
(C) Buried surface area of MHC or peptide for each peptide/Class I MHC/TCR complex (Dodson, 1997).
(D) Shape complementarity of each TCR for pMHC as calculated with sc (Lawrence and Coleman, 1993) and implemented in ccp4 (Dodson, 1997).
A Xenoreactive TCR Docks Nondiagonally
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A2 are different from the structures of the six of the sevenTable 3. Contacts between AHIII 12.2 TCR and p1049/A2
previously examined Class I pMHC/TCR structures. The
TCR pMHC TCR pMHC
CDR1 loop of AHIII 12.2 interacts with residues
CDR1 CDR1 154,155,158, 162, 163, and 167 of p1049/A2; other TCR
Y28 G162 Y31 pF6 CDR1s interact with residues around 58 and 62. The
T163
nearly orthogonal JM22 TCR uses many fewer CDR1E166
contacts, but those that it does make are at residuesW167
154 and 155, like AHIII 12.2. The AHIII 12.2 CDR2 inter-S29 A158
S31 E154 acts with MHC residues around 151 as does JM22. How-
Q155 ever, in other TCRs, the CDR2 loops contact residues
A158 near 158 (not 151). The CDR3 of AHIII 12.2 interacts
CDR2 CDR2
with MHC residues across the peptide binding groove.TCR pMHC TCR pMHC
AHIII 12.2 interacts with 65 and 69 of the 1 domain ofF50 H151 Y48* R65
A2 and 155, 158, 159, and 163 of the 2 domain of A2.E154 Y50 K68
T51 H151 V51 Q72 CDR3 of other TCR rarely interact with residues in the
E56 R65 2 domain (except for one contact in LC13 and one in
CDR3 CDR3 KB5-C20). The CDR1 loop of AHIII 12.2 interacts with
TCR pMHC TCR pMHC
the peptide at phenylalanine at P6 but not the MHC;E93 Q155 W97 K146
other TCRs interact with MHC residues around 76. ThepF5 W147
CDR2 loop of AHIII 12.2 interacts with residues aroundA97 pW3 A150
pG4 V152 68 (65, 68, and 72); the CDR2 loops of other TCRs
pF5 pF5 interact with residues around 76, but not 68. The CDR3
S98 A158 pF6 chain contacts MHC residues solely in the 2 domain
Y159 pP7
of A2 (146, 147, 149, 150, 152, and 155). Therefore, theT163 pV8
types and quantities of interactions that AHIII 12.2 usespW3 V98 A150
to recognize p1049/A2 may appear to be similar to rec-pG4 S99 pF5
S99 K66 Y100 A149 ognition by other TCRs, but the specific MHC residues




The “p” before a pMHC residue denotes that contact comes from The murine T cell AHIII 12.2 recognizes human pMHC
the peptide p1049.3
p1049/A2, and the crystal structure of this murine TCR
in complex with its human pMHC ligand proves that
xenoreactive recognition is functionally equivalent to
recognition of pMHC by any TCR. Indeed, recognition
by AHIII 12.2 has been shown to be peptide specificmediated by the  and  chain CDR3 loops (Table 3).
(Loftus et al., 1997), analogous to normal TCR recogni-The p1049 central residues, P5 and P6, are phenylala-
tion of syngeneic pMHC. However, the AHIII 12.2 TCRnine, and both rings are oriented edge on to the TCR.
is bound to p1049/A2 in an orientation that is nearlyIn combination with the aliphatic residues on the A2 
perpendicular to the direction of the p1049 peptide, un-helices, this produces a rather flat interaction surface
like the more diagonal TCR binding in previously charac-that results in little interpenetration of either the peptide
terized TCR/pMHC complexes. Binding of AHIII 12.2or the TCR side chains during binding. There are an
TCR to p1049/A2 is tight (10M) (Buslepp et al., 2003),equivalent number of contacts between the peptide and
but not tighter than the previously characterized TCR/the variable domains of the  and  chains of the TCR,
pMHC structures. This clearly shows that a specific TCRbut the mechanism of interaction is different between
orientation is not required for pMHC binding of sufficientthe two domains. The CDR1 and CDR2 loops do not
affinity to activate normal CTL function (Buslepp et al.,interact with peptide. CDR3 uses six residues to make
2003). The number of contacts AHIII 12.2 makes withseven contacts from the Trp at P3 to the Phe at P5. The
p1049 and HLA-A2 are not less than that of other TCR,CDR1 makes one contact with p1049/A2 with the Phe
demonstrating that a diagonal TCR orientation is notat P6. Like the CDR2 chain, CDR2makes no contacts
required for adequate interactions with peptide or MHC.with the peptide. CDR3 uses five amino acids to make
Although the TCR orientation adopted by AHIII 12.2six contacts with the peptide.
during recognition of p1049/A2 is atypical, it is unrea-
sonable to assume that this anomaly is the result of a
unique property of the AHIII 12.2 TCR. The AHIII 12.2Recognition of MHC
There are no conserved contacts between pMHC and TCR also recognizes H2 Db in complex with peptide
p1058 in a syngeneic manner, and while a structure ofTCR observed in the cocrystals of TCR/pMHC to date
(Rudolph and Wilson, 2002). Instead, there are regions AHIII 12.2 in complex with Db-p1058 would undoubtedly
add important information to our analysis, extensive ef-that are consistently involved in binding by virtue of
the limited number of possibilities given the conserved forts to crystallize the AHIII 12.2 with Db-p1058 have
been unsuccessful. Nonetheless, earlier peptide muta-docking orientation. However, the regions that the mu-
rine AHIII 12.2 TCR uses to interact with human p1049/ genesis studies that compared the influence of alanine-
Immunity
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scanning mutations in p1049 (bound to A2) and p1058 resulting in ITAM phosphorylation and initiation of the
T cell signaling cascade.(bound to Db) on CTL lysis by AHIII 12.2 demonstrated
The necessity of CD8 for positive selection of Classthat while mutations to the center of the p1049 peptide
I-restricted thymocytes has been recognized for severalinhibited A2-mediated CTL activity, mutations at the
years. Knockout mice lacking either CD8 or CD8 haveC-terminal end of the p1058 peptide abrogated CTL
few if any CD8 T cells, indicating that double positivelysis of p1058/Db (Loftus et al., 1997). These results are
T cells do not transition to the CD8 single positive stageconsistent with the orthogonal position of the AHIII 12.2
when CD8 is absent (Crooks and Littman, 1994; Fung-TCR atop p1049/A2 and imply that AHIII 12.2 recognition
Leung et al., 1991, 1994). Additionally, injection ofof p1058/Db assumes the canonical diagonal orientation.
blocking anti-CD8 antibodies into sublethally irradiatedThere is not a set of conserved contacts that generate
mice results in a selective loss of CD8 thymocytesthe common docking mode of TCR on pMHC (Baker et
(Ramsdell and Fowlkes, 1989). During T cell develop-al., 2001; Rudolph and Wilson, 2002; Wang et al., 2002).
ment, double positive thymocytes undergo positive andOur data demonstrate that there is not a requirement
negative selection during the transition into mature sin-for a conserved TCR orientation with respect to pMHC
gle positive T cells, and these selection processes areinteractions or activity. However, we have identified a
mediated by the affinity of MHC for TCR (Sebzda et al.,likely explanation for the various degrees of difference
1999). Positive selection involves TCR recognition ofin TCR orientation atop pMHC. Two distinct populations
self-peptide/self-MHC complexes, yet the affinity of theof TCR V domain positions exist, and these distinct
TCR/pMHC interaction during positive selection is atgroups can be separated on the basis of CD8 depen-
least an order of magnitude lower than that necessarydence. The canonical group of CD8-dependent diagonal
for TCR recognition of antigenic pMHC (Alam et al.,binding TCRs, 2C, A6, B7, and KB5-C20, represent one
1996). In order to reconcile this disparity, recent datagroup, while a second group contains AHIII 12.2, BM3.3
suggest that CD8 contains poorly sialylated O-glycansand LC13, and JM22, which are all CD8 independent.
during the developmental stage, greatly increasing itsStudies have shown that 2C and KB5-C20 are CD8 de-
affinity for pMHC (Daniels et al., 2001; Moody et al.,pendent (Daniels and Jameson, 2000; Guimezanes et
2001), much more so than is predicted for CD8/pMHCal., 2001). In addition, A6 and B7 have shown depen-
interactions based upon Biacore experiments (Garcia etdence on CD8 in CTL assays using anti-CD8 antibodies
al., 1996b; Kern et al., 1999; Wyer et al., 1999). Thus, an(data not shown). Similarly, AHIII 12.2 and BM3.3 are
increased affinity between pMHC and CD8, in spite ofCD8 independent with respect to their cocrystalized
a decrease in affinity between TCR and pMHC, accountspMHC, as the presence of anti-CD8 blocking antibody
for the interaction between TCR and self-pMHC duringdoes not alter recognition (Buslepp et al., 2003; Guimez-
positive selection. What then is the purpose of TCR ori-anes et al., 2001). V17 containing Flu matrix peptide
entation?(MP)-specific TCR clones, such as JM22, are remarkably
Our work provides unique structural insights into theconserved between different donors (Moss et al., 1995),
requirements for CD8 in T cell positive selection. Sinceand V17 TCR are CD8 independent in studies with
the first structure of a TCR/pMHC complex was deter-blocking human anti-CD8 antibody (Lawson et al., 2001).
mined, it has been suggested that TCR orientation actsThus, we infer that JM22 is CD8 independent. Finally,
as a “filtration” step during positive selection in the thy-soluble CD8 (Sewell et al., 1999) does not inhibit lysis
mus, “selecting” TCR that bind pMHC in a diagonalof EBV-infected HLA B8 positive cell lines (LCLs) by
manner (Bankovich and Garcia, 2003; Garboczi et al.,LC13 (S. Burrows, personal communication); however, a
1996). We propose that the interaction of self-pMHCFLU-B8-reactive CTL clone, PP36, is inhibited by soluble
complexes with TCR during positive selection requiresCD8 in the same assay. These data suggest that the
a precise orientation for correct positioning of pMHCorientation of TCR on pMHC, and in particular the posi-
and TCR with respect to CD8. We believe that TCR
tion of the TCR V domain, ensures optimal coordination
recognition during development involves a type of “lock
of the CD8 coreceptor with the TCR/pMHC complex.
and key” mechanism for the interaction of TCR with
Additionally, these data imply that the TCR V positions the self-pMHC/CD8 complex that is only present during
of AHIII 12.2, BM3.3, JM22, and LC13 sterically hinder selection due to inadequately sialylated O-glycans (Dan-
association of the TCR/pMHC complex with CD8. iels et al., 2001; Moody et al., 2001). This filter allows
CD8 is expressed as an / heterodimer on the major- only TCR that bind in a specific orientation to “fit” with
ity of CD8 / TCR T cells. The intracellular tail of the self-pMHC/CD8, and thus survive positive selection via
CD8 chain is palmitylated to enhance association with initiation of the appropriate signaling transduction cas-
cholesterol-containing microdomains (Arcaro et al., cade (Figure 4). In the absence of the correct geometry
2000). Two cysteines in the intracellular tail of CD8 between TCR, MHC, and CD8, no signal would be pro-
share coordination of a zinc with the src-family kinase, duced and positive selection would not occur. This pro-
p56lck (Lin et al., 1998; Shaw et al., 1990; Turner et al., posed mechanism explains how TCR recognizes self-
1990). The N-terminal Ig-like V domains of CD8 binds pMHC with low affinity during T cell development, yet
residues in the 2 and 3 domains of the class I MHC higher affinity TCR/pMHC interactions are required for
heavy chain (Gao et al., 1997; Kern et al., 1998; Sewell T cell activation in the periphery. While we assume selec-
et al., 1999). Additionally, interactions between the CD8 tion would occur in a similar manner for CD4 T cells,
stalk region and the FG loop in the constant domain of we expect the structural differences between CD4 and
the TCR chain have been proposed previously (Sasada CD8 molecules to necessitate a different TCR domain
et al., 2002). Upon binding of pMHC by TCR and CD8, positioning. At this point there is not enough structural
information on Class II MHC-restricted TCRs to ade-p56lck is brought in proximity to the ITAMs of CD3,
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Figure 4. Model for CD8-Dependent and CD8-Independent T Cell Signaling
(Left) The TCR docks diagonally with pMHC that allows for correct positioning of CD8/ heterodimer on the left. Positioning of CD8 juxtaposes
p56lck with the CD3 chain ITAM and begins the signaling cascade.
(Right) In the CD8-independent example, the affinity of TCR for pMHC is such that CD8 is recruited to the immunological synapse in the
absence of binding to MHC. The local concentration of p56lck is sufficient to phosphorylate CD3 ITAMS without direct juxtaposition. CD8
independence is unlikely to happen during T cell selection because the increased affinity would trigger negative selection.
quately predict how selection of CD4 TCR may occur. we believe that this example only strengthens the idea
that CD8 dependence is determined by V domain posi-Finally, our proposed geometric filtering model for posi-
tive selection would be consistent with either instruc- tioning. The basis for the considerable differences in
functional characteristics between the KB5-C20 andtional or stochastic lineage commitment.
Several groups have shown that increasing the affinity BM3.3 alloreactive systems has been described pre-
viously (Guimezanes et al., 2001).between TCR and pMHC will result in positive selection
even in the absence of CD8 (Goldrath et al., 1997; Sher- The LC13 and JM22 TCR are two examples of immu-
nodominant TCR, and interestingly, both are CD8 inde-man et al., 1992). Yet these T cells positively selected
due to expression of a TCR with high affinity for self- pendent. LC13 recognizes Epstein Barr (EBV) viral pep-
tide FLRGRAYGL complexed with HLA-B8, while JM22pMHC are removed during negative selection (Sebzda
et al., 1999). We suggest that those TCR that are CD8 recognizes the influenza A MP in complex with HLA-A2.
We predict that during selection, these two TCR interactindependent have increased affinity for self-pMHC, and
typically are removed during negative selection. Both with self-pMHC in a diagonal orientation with the V
domain in the canonical position. Yet both the MP/A2the AHIII 12.2 and BM3.3 TCR were selected during
T cell development on a different genetic background and FLRGRAYGL/B8 pMHC ligands provide a unique
molecular surface that induces an enhanced, albeit non-than the pMHC in their cocrystal structures; AHIII 12.2
was selected on a mouse H2b background, while BM3.3 canonical, fit for the JM22 and LC13 TCR, respectively
(Kjer-Nielsen et al., 2003; Stewart-Jones et al., 2003),was selected on an H2k background. Additionally, both
the AHIII 12.2 and BM3.3 TCR are of very high affinity when encountered in the periphery. The enhanced fit
likely permits the CD8-independence of these two TCRs,in comparison to that of typical syngeneic TCR/pMHC
interactions (Buslepp et al., 2003; Garcia et al., 1999; and conveys superior expansion of a clonal, immuno-
dominant T cell population. As EBV causes persistentReiser et al., 2000). Therefore, the V domain positions
of AHIII 12.2 and BM3.3 atop their crossreactive ligands infection in 90% of adults (Moss et al., 2001) and MP-
specific T cells are continuously present in the memoryare a snapshot of additional V chain orientations found
in the absence of selective pressures imposed by CD8 pool, this scheme may be a tactic employed by viruses
to impair the T cell immune response. Several molecularduring thymic development. Finally, the KB5-C20 TCR
is alloreactive, but adopts the canonical Vdomain posi- mechanisms used by viruses to evade detection by
the immune system have already been characterizedtion during recognition of pKB1/Kb. As KB5-C20 is CD8
dependent and interacts with pKB1/Kb with low affinity (Ploegh, 1998).
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Arcaro, A., Gregoire, C., Boucheron, N., Stotz, S., Palmer, E., Malis-An AHIII 12.2 TCR transgenic mouse is being gener-
sen, B., and Luescher, I.F. (2000). Essential role of CD8 palmitoyla-ated to explore the T cell repertoire selected when TCR/
tion in CD8 coreceptor function. J. Immunol. 165, 2068–2076.pMHC binding is non-canonical during T cell develop-
Bachmann, M.F., Salzmann, M., Oxenius, A., and Ohashi, P.S. (1998).ment. We expect these mice and future experiments to
Formation of TCR dimers/trimers as a crucial step for T cell activa-
allow us to conclusively show that geometric filtering is tion. Eur. J. Immunol. 28, 2571–2579.
a required part of positive selection.
Baker, B.M., Turner, R.V., Gagnon, S.J., Wiley, D.C., and Biddison,
W.E. (2001). Identification of a crucial energetic footprint on the al
Experimental Procedures helix of human histocompatibility leukocyte antigen (HLA)-A2 that
provides functional interactions for recognition by tax peptide/HLA-
Protein Production and Crystallization A2-specifrc T cell receptors. J. Exp. Med. 193, 551–562.
The  and  chains of the soluble AHIII 12.2 TCR were produced in
Bankovich, A.J., and Garcia, K.C. (2003). Not just any T cell receptorE. coli as inclusion bodies and refolded to the native state in vitro
will do. Immunity 18, 7–11.as described (Buslepp et al., 2003). Similarly, Class I MHC was
Buslepp, J., Kerry, S.E., Loftus, D., Frelinger, J.A., Appella, E., andproduced as inclusion bodies in E. coli and refolded (Garboczi et
Collins, E.J. (2003). High affinity xenoreactive TCR:MHC interactional., 1992). Crystals of the AHIII 12.2/p1049/A2 complex were grown
recruits CD8 in absence of binding to MHC. J. Immunol. 170,by hanging drop, vapor diffusion, using a 1:1 mixture containing 10
373–383.mg/ml of each protein. Initial crystals were grown in 12% PEG 8000,
25 mM HEPES (pH 7.1), 1 M NaCl conditions and were improved Carson, M. (1987). Ribbon models of macromolecules. J. Mol. Graph.
by macro seeding in identical conditions except substituting with 5, 103–106.
PEG 3350. Crystals were transferred to mother liquor containing
Crooks, M.E., and Littman, D.R. (1994). Disruption of T lymphocyte25% glycerol cryoprotectant. Crystals diffracted to 2.6 A˚ on a rotat-
positive and negative selection in mice lacking the CD8 beta chain.ing anode, but were significantly improved by data collection with
Immunity 1, 277–285.synchrotron radiation. Data were collected at NSLS beamline X12b
Daniels, M.A., Devine, L., Miller, J.D., Moser, J.M., Lukacher, A.E.,at 12189ev (1.017 A˚), at a distance of 150 mm using 1.0 oscillations.
Altman, J.D., Kavathas, P., Hogquist, K.A., and Jameson, S.C. (2001).The refined mosaicity is 0.51. Data were indexed and scaled with
CD8 binding to MHC class I molecules is influenced by T cell matura-HKL2000 (Otwinowski, 1997). Data statistics are shown in Table 1.
tion and glycosylation. Immunity 15, 1051–1061.
Daniels, M.A., and Jameson, S.C. (2000). Critical role for CD8 in T cellStructure Determination and Refinement
receptor binding and activation by peptide/major histocompatibilityThe phases for the cocrystal were determined by molecular replace-
complex multimers. J. Exp. Med. 191, 335–346.ment using AMoRe as implemented in the CCP4 package (Dodson,
1997; Navaza, 1997). The search models used were p1049/A2 Davis, M.M., and Bjorkman, P.J. (1988). T-cell antigen receptor
(1BOG) and the 2C TCR (1TCR). There was a single rotation solution. genes and T-cell recognition. Nature 334, 395–402.
Visual inspection of the resulting packing based on the molecular
Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., and
replacement solution showed sufficient space for a second TCR/
Wiley, D.C. (1998). Two human T cell receptors bind in a similar
pMHC complex. Examination of the translation results showed a
diagonal mode to the HLA-A2/Tax peptide complex using different
second translation solution almost half a cell length along the crys-
TCR amino acids. Immunity 8, 403–411.
tallographic a and b axes with the same rotations as the first solution.
Ding, Y.H., Baker, B.M., Garboczi, D.N., Biddison, W.E., and Wiley,The final correlation coefficient after fitting both complexes was
D.C. (1999). Four A6-TCR/peptide/HLA-A2 structures that generate57.0 and the Rfac was 36.4%. Temperature factors were set to 20.0
very different T cell signals are nearly identical. Immunity 11, 45–56.and the data were rigid body fit with Refmac 5.0 (Murshudov et al.,
1997). Positional refinement using both noncrystallographic symme- Dodson, E.J., Winn, M., and Ralph, A. (1997). Collaborative Compu-
try restraints and TLS refinement (Winn et al., 2001) to correct for tational Project, Number 4: Providing Programs for Protein Crystal-
domain-specific anisotropic temperature factors was performed it- lography. In Methods Enzymol., C.W. Carter and R.M. Sweet, eds.
eratively with manual intervention using O (Jones et al., 1991). Pep- (New York, NY, Academic Press), pp. 620–633.
tide p1049 was not included in the model until the Rfree dropped Engelhard, V.H., and Benjamin, C. (1982). Isolation and characteriza-
below 30.0% as an internal control for model bias. When the statis- tion of monoclonal mouse cytotoxic T lymphocytes with specificity
tics did not improve over two subsequent rounds as described for HLA-A,B or -DR alloantigens. J. Immunol. 129, 2621–2629.
above and the Rfree was below 30%, waters were added using Arp
Fung-Leung, W.P., Schilham, M.W., Rahemtulla, A., Kundig, T.M.,(Perrakis et al., 2001). All waters were examined visually and had to
Vollenweider, M., Potter, J., van Ewijk, W., and Mak, T.W. (1991).be within 2.6–3.2 A˚ from two hydrogen bond donor or acceptors to
CD8 is needed for development of cytotoxic T cells but not helperbe included in the model. The refinement statistics for the final
T cells. Cell 65, 443–449.model are shown in Table 1.
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